Middle East and Africa Iodinated Contrast Media in Interventional X-Ray Market - Industry Trends and Forecast To 2027

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 APPLICATION GRID

2.9 DBMR MARKET POSITION GRID

2.10 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTION

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 LARGE NUMBER OF APPROVALS FOR IODINATED AGENTS

3.1.2 RISING AGING POPULATION

3.1.3 INCREASING NUMBER OF CHRONIC DISEASES

3.1.4 INCREASING RESEARCH ACTIVITIES FOR CONTRAST AGENTS

3.2 RESTRAINTS

3.2.1 HIGH COST OF CONTRAST MEDIA

3.2.2 SIDE EFFECTS ASSOCIATED WITH CONTRAST AGENTS

3.3 OPPORTUNITIES

3.3.1 GROWING HEALTHCARE INFRASTRUCTURE

3.3.2 STRATEGIC INITIATIVE BY MARKET PLAYERS

3.3.3 GROWING NUMBER OF DIAGNOSTIC CENTERS

3.3.4 UPCOMING GENERIC CONTRAST MEDIA AGENTS

3.4 CHALLENGES

3.4.1 LACK OF AWARENESS REGARDING THE PROPER DOSAGE OF CONTRAST AGENT

3.4.2 RESTRICTION AND WITHDRAWAL OF LINEAR GADOLINIUM-BASED CONTRAST AGENTS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION

6.1 OVERVIEW

6.2 INTRAVENOUS

6.3 ORAL

6.4 RECTAL

6.5 OTHERS

7 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER

7.1 OVERVIEW

7.2 HOSPITAL

7.3 SPECIALTY CLINICS

7.3.1 IMAGING CENTERS

7.3.2 PRIVATE PRACTICES

7.4 DIAGNOSTIC CENTERS

7.5 AMBULATORY SURGICAL CENTERS

7.6 RESEARCH & ACADEMIC INSTITUTES

8 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION

8.1 OVERVIEW

8.2 CARDIOLOGY

8.2.1 PERCUTANEOUS CORONARY DISEASE

8.2.2 STRUCTURAL HEART DISEASE

8.2.3 CONGENITAL HEART DISEASE

8.2.4 ELECTROPHYSIOLOGY

8.3 NEUROLOGY

8.4 GENERAL SURGERY

8.5 ONCOLOGY

8.6 UROLOGY

9 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE

9.1 OVERVIEW

9.2 NON-IONIC

9.3 IONIC

10 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY GEOGRAPHY

10.1 MIDDLE EAST AND AFRICA

10.1.1 U.A.E.

10.1.2 SAUDI ARABIA

10.1.3 EGYPT

10.1.4 SOUTH AFRICA

10.1.5 ISRAEL

10.1.6 REST OF MIDDLE EAST & AFRICA

11 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, COMPANY LANDSCAPE

11.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

12 COMPANY PROFILES

12.1 BRACCO DIAGNOSTIC INC.

12.1.1 COMPANY SNAPSHOT

12.1.2 COMPANY SHARE ANALYSIS

12.1.3 PRODUCT PORTFOLIO

12.1.4 RECENT DEVELOPMENT

12.2 GENERAL ELECTRIC

12.2.1 COMPANY SNAPSHOT

12.2.2 REVENUE ANALYSIS

12.2.3 COMPANY SHARE ANALYSIS

12.2.4 PRODUCT PORTFOLIO

12.2.5 RECENT DEVELOPMENTS

12.3 GUERBET

12.3.1 COMPANY SNAPSHOT

12.3.2 REVENUE ANALYSIS

12.3.3 COMPANY SHARE ANALYSIS

12.3.4 PRODUCT PORTFOLIO

12.3.5 RECENT DEVELOPMENT

12.4 BAYER AG

12.4.1 COMPANY SNAPSHOT

12.4.2 REVENUE ANALYSIS

12.4.3 PRODUCT PORTFOLIO

12.4.4 RECENT DEVELOPMENT

12.5 IMAX

12.5.1 COMPANY SNAPSHOT

12.5.2 PRODUCT PORTFOLIO

12.5.3 RECENT DEVELOPMENT

12.6 ISO-TEX DIAGNOSTICS, INC.

12.6.1 COMPANY SNAPSHOT

12.6.2 PRODUCT PORTFOLIO

12.6.3 RECENT DEVELOPMENT

12.7 J.B.CHEMICALS AND PHARMACEUTICALS LTD.

12.7.1 COMPANY SNAPSHOT

12.7.2 REVENUE ANALYSIS

12.7.3 PRODUCT PORTFOLIO

12.7.4 RECENT DEVELOPMENT

12.8 NOVALEK PHARMACEUTICALS PVT. LTD.

12.8.1 COMPANY SNAPSHOT

12.8.2 PRODUCT PORTFOLIO

12.8.3 RECENT DEVELOPMENT

12.9 TAEJOON PHARM

12.9.1 COMPANY SNAPSHOT

12.9.2 PRODUCT PORTFOLIO

12.9.3 RECENT DEVELOPMENT

12.10 UNIJULES LIFE SCIENCES LTD.

12.10.1 COMPANY SNAPSHOT

12.10.2 PRODUCT PORTFOLIO

12.10.3 RECENT DEVELOPMENT

13 QUESTIONNAIRE

14 RELATED REPORTS

UU

TABLE 1 LIST OF FDA APPROVED NON-IONIC IODINATED AGENTS

TABLE 2 LIST OF FDA APPROVED IONIC IODINATED AGENTS

TABLE 3 COST OF CONTRAST MEDIA

TABLE 4 LIST OF UPCOMING GENERIC CONTRAST MEDIA AGENTS

TABLE 5 DOSAGE OF CONTRAS MEDIA TO BE TAKEN AS PER PATIENT’S WEIGHT

TABLE 6 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 7 MIDDLE EAST AND AFRICA INTRAVENOUS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 8 MIDDLE EAST AND AFRICA ORAL IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 9 MIDDLE EAST AND AFRICA RECTAL IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 10 MIDDLE EAST AND AFRICA OTHERS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 11 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA HOSPITAL IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 13 MIDDLE EAST AND AFRICA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 14 MIDDLE EAST AND AFRICA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 15 MIDDLE EAST AND AFRICA DIAGNOSTIC CENTERS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 16 MIDDLE EAST AND AFRICA AMBULATORY SURGICAL CENTERS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 17 MIDDLE EAST AND AFRICA RESEARCH & ACADEMIC INSTITUTES IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 19 MIDDLE EAST AND AFRICA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 20 MIDDLE EAST AND AFRICA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 21 MIDDLE EAST AND AFRICA NEUROLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 22 MIDDLE EAST AND AFRICA GENERAL SURGERY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA ONCOLOGY SURGERY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 24 MIDDLE EAST AND AFRICA UROLOGY SURGERY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 25 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 26 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITER)

TABLE 27 MIDDLE EAST AND AFRICA NON-IONIC IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 28 MIDDLE EAST AND AFRICA IONIC IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 29 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 30 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 31 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 32 MIDDLE EAST AND AFRICA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 33 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 34 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 35 MIDDLE EAST AND AFRICA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 36 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 37 U.A.E. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 38 U.A.E. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 39 U.A.E. CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 40 U.A.E. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 41 U.A.E. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 42 U.A.E. SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 43 U.A.E. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 44 U.A.E. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 45 SAUDI ARABIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 46 SAUDI ARABIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 47 SAUDI ARABIA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 48 SAUDI ARABIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 49 SAUDI ARABIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 50 SAUDI ARABIA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 51 SAUDI ARABIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 52 SAUDI ARABIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 53 EGYPT IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 54 EGYPT IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 55 EGYPT CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 56 EGYPT IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 57 EGYPT IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 58 EGYPT SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 59 EGYPT IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 60 EGYPT IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 61 SOUTH AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 62 SOUTH AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 63 SOUTH AFRICA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 64 SOUTH AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 65 SOUTH AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 66 SOUTH AFRICA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 67 SOUTH AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 68 SOUTH AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 69 ISRAEL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 70 ISRAEL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 71 ISRAEL CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 72 ISRAEL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 73 ISRAEL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 74 ISRAEL SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 75 ISRAEL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 76 ISRAEL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 77 REST OF MIDDLE EAST & AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION